Evaluation of extracts from Coccoloba mollis using the Salmonella/microsome system and in vivo tests by Tsuboy, Marcela Stefanini et al.
Evaluation of extracts from Coccoloba mollis using the Salmonella/microsome
system and in vivo tests
Marcela Stefanini Tsuboy
1, Juliana Cristina Marcarini
1, Dalva Trevisan Ferreira
2,
Elisa Raquel Anastácio Ferraz
3, Farah Maria Drumond Chequer
3, Danielle Palma de Oliveira
3,
Lúcia Regina Ribeiro
4 and Mário Sérgio Mantovani
1
1Departamento de Biologia Geral, Universidade Estadual de Londrina, Londrina, PR, Brazil.
2Departamento de Química, Universidade Estadual de Londrina, Londrina, PR, Brazil.
3Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências
Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
4Instituto de Biociências, Universidade Estadual Paulista “Júlio de Mesquita Filho”, Rio Claro, SP, Brazil.
Abstract
The common everyday use of medicinal plants is an ancient, and still very widespread practice, whereby the need for
studies on their possible toxicity and mutagenic properties. The species Coccoloba mollis has been much used in
phytotherapy, mainly in cases involving loss of memory and stress. In order to investigate its genotoxic and
mutagenic potential, ethanolic extracts from the leaves and roots underwent Salmonella/microsome assaying (TA98
and TA100 strains, with and without exogenous metabolism – S9), besides comet and micronucleus tests in
vivo.There was no significant increase in the number of revertants/plate of Salmonella strains in any of the analyzed
root-extract concentrations, although the extract itself was extremely toxic to the Salmonella TA98 strain in the tests
carried out with S9 (doses varying from 0.005 to 0.5 g/plate). On the other hand, the leaf-extract induced mutations
in the TA98 strain in the absence of S9 in the highest concentration evaluated, although at very low mutagenic po-
tency (0.004 rev/g). Furthermore, there was no statistically significant increase in the number of comets and
micronuclei, in treatments involving Swiss mice. It was obvious that extracts of Coccoloba mollis, under the de-
scribed experimental conditions, are not mutagenic.
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Introduction
The use of plants for medicinal purposes is one of the
oldest forms of medical practice. Besides this practice con-
tinuing to be important in primary health care of the less
fortunate population in developing countries, the procure-
ment of medications of natural origin in developed coun-
tries has increased considerably in the last decades (WHO,
2000). Therefore, special attention should be given to the
evaluation of the safety, efficacy and quality of natural
products, which includes the evaluation of natural thera-
peutic agents for genotoxicity/mutagenicity as recom-
mended by national and international regulatory agencies
(CNS, 1997; OECD, 2001).
Although there is scientific endorsement of the nu-
merousbenefitsarisingfrommedicinalplants,theirgeneral
use should be viewed with caution. Adverse effects can de-
velop due to intrinsic toxicity, adulteration, substitution,
contamination, the erroneous identification of plant mate-
rial, the lack of inspection, and the interaction with other
drugs (Rates, 2001; Zhou et al., 2004).
The species Coccoloba mollis Casaretto
(Polygonaceae) is commonly used for phytotherapeutic
purposes under the name of “Erva da memória” or the
memory herb. The popular use of this plant has been re-
ported as beneficial in cases of memory loss, stress, insom-
nia, anemia, diminishing eyesight and sexual impotency.
Theproductismanuallypreparedinextractformwithalco-
hol from the roots and leaves of the plant. Once prepared, it
is kept in the dark for about 15 days. Users are recom-
mended to ingest 10 drops of the tincture diluted in water,
two or three times a day. The species, popularly known as
folha-de-bôlo or falso-novateiro, occurs in shrublands and
semideciduousforestsintheParanaRiverbasin,inthecen-
ter-southern region of Brazil (Lorenzi, 2002). Species of
the genus Coccoloba have been used in astringent form, in
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Research Articlethe treatment of fever, diarrhea, gonorrhea, hemorrhoids,
menstruation problems and uterine hemorrhage (Mors et
al., 2000; Cota et al., 2003). Nevertheless to date no infor-
mation is available in the scientific literature, as to the bio-
logical effects on in vitro and in vivo systems. On
considering the genus Coccoloba, and the importance of
scientific evaluation of medicinal plants of common use|,
the aim was to determine the genotoxicity/mutagenicity of
leaf and root ethanolic extracts from Coccoloba mollis by
using Salmonella/microsome assaying (Ames test), as well
as in vivo ± and micronucleus tests.
Materials and Methods
Extracts of Coccoloba mollis
A dried, powdered material (from both leaves and
roots)wasextractedwith95%ethanolatroomtemperature,
the solvent then being removed under vacuum to yield 40 g
of root extract (RE) and 85 g of leaf extract (LE). The leaf
material underwent successive fractional partitioning by
ethyl acetate. These fractions (30 g) were then chromato-
graphed on a silica gel (174 g) column using increasing po-
larity solvents (n-hexane, dichloromethane and ethyl
acetate). The root extract also underwent successive frac-
tional partitioning by n-hexane and ethyl acetate. The hex-
ane soluble fraction (4,5 g) was chromatographed on a
silica gel (163,66 g) column using increasing polarity sol-
vents (n-hexane, dichloromethane, ethyl acetate). The ma-
jor extract compounds, identified by spectroscopy (NMR,
1H/
13C, CG-MS, IV), were a mixture of long chain hydro-
carbons, carboxyl esters and 3-taraxerone (a triterpene) in
the leaf extract, and two anthraquinones (emodin and
physcion) in the root. The plants collected were identified
by Ana Odete Santos Vieira, PhD from the Department of
Animal and Vegetal Biology of the Universidade Estadual
de Londrina, UEL. A voucher specimen was deposited un-
der number Barros, I B 001.
IntheSalmonella/microsomeassay,theextractswere
resuspended in dimethylsulfoxide (DMSO), using test con-
centration limits, as recommended in the literature (Mor-
telmans and Zeiger, 2000; SBMCTA, 2004). Based on this
recommendation, pure substances or extracts should be
testedeitheratamaximalconcentrationof5mg/plate,orup
to their respective solubility limit. Thus, the root extract
(RE) was tested at a concentration of 5 mg/plate, whereas
the leaf extract (LE) was tested at a lower maximal concen-
tration of 3 mg/plate, due to limited solubility. Initially, as-
saying was carried out with five concentrations based on a
logarithmic scale, in order to determine the range of muta-
genic concentrations, if present. Based on this preliminary
assay, new test concentrations were chosen
Prior to administration to animals, both extracts (LE
and RE) were dissolved in DMSO and PBS (phosphate
buffersaline),theDMSOconcentrationnotexceeding10%
of the total volume of the mother solution in preparation.
They were then filtered with 0.22 m porosity disposable
filters (Millex
® - Millipore), and subsequently sterilized.
Administration was via gavage.
Experimental animals
Fifty-six male Swiss mice (Mus musculus), each
weighing approximately 30 g, were distributed into control
and experimental groups, consisting of seven animals per
treatment, eight groups all told. They were kept in the Ani-
mal House for Small Mammals of the Department of Gen-
eral Biology, Biological Sciences Center, Londrina State
University (CCB/UEL), under controlled conditions as to
temperature (22  2 °C), humidity (55  10%) and photo-
period(12h).Theanimalsweregivensolidrationsandwa-
ter ad libitum during the entire experimental period.
Experimental protocols and procedures for
Salmonella/microsome assaying (Ames test)
The protocol employed was that with pre-incubation,
according to Maron and Ames (1983) and Mortelmans and
Zeiger (2000). Briefly, 100 L of culture from each strain
(10
9 cells/mL) were placed in previously sterilized tubes,
where upon 100 L of each extract solution at different
concentrations were added, together with 500 L of 0.2 M
phosphate buffer for the assay in the absence of metabolic
activation,orthesamevolumeoftheS9mixturewithmeta-
bolic activation. Tube contents were mixed and incubated
at 37 °C for 30 min. 2.0 mL of surface agar were added, the
tubes were mixed, and the mixture was poured into a Petri
dish with 20 mL of minimum agar. The plates were incu-
bated upside down for 66 h at 37 °C (0.5). The test was
performedintriplicate.Forthisstudy,thestrainsTA98and
TA100 were chosen, which detect the majority of muta-
genic compounds, as the first detects frameshift mutations,
whereas the second identifies base-pair substitutions (Ma-
ron and Ames, 1983).
DMSOwasusedasnegativecontrol.Aspositivecon-
trol in the tests without S9, 4-nitroquinoline-1-oxide
(4NQO; CAS number 56-57-5), was used at a concentra-
tion of 0.5 g/plate. For the tests carried out in the presence
of S9, the positive control was 2-aminoanthracene (2AA;
CAS number 613-13-8) at a concentration of 2.5 g/plate.
The background was carefully examined to check
toxicity. Samples were considered toxic when a thinning of
the background lawn was observed. This may be accompa-
nied by a decrease in the number of revertants, the absence
ofabackgroundlawnorpresenceofpinpointnon-revertant
colonies, generally in conjunction with an absence of a
background lawn according to Mortelmans and Zeiger
(2000). The colonies were counted manually. Samples
wereconsideredpositivewhenANOVAanddoseresponse
were both significant when using the Bernstein model
(Bernstein et al., 1982; Umbuzeiro and Vargas, 2003). The
results were submitted to statistical analysis using Salanal,
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Experimental protocols and procedures for in vivo
comet and micronucleus assays
The experimental animals were distributed into eight
groups: (1) negative control; (2) positive control (cyclo-
phosphamide; CAS number 6055-19-2; 50 mg/kg body
weight); (3/4) [LE1]/[RE1] (dose 1 of LE and RE - 6.6 x
10
-3 mg/kg b.w.); (5/6) [LE 2]/[RE 2] (dose 2 of LE and RE
-6 . 6x1 0
-2 mg/kg b.w.); and (7/8) [LE 3]/[RE 3] (dose 3 of
LE and RE - 6.6 x 10
-1 mg/kg b.w.).
In group 1 (negative control), PBS was administered
via gavage and intraperitoneally, whereas in group 2 (posi-
tive control), PBS was via gavage and cyclophosphamide
(50 mg/kg) intraperitoneally. In animals pertaining to the
groups for determination of extract genotoxicity (3 to 8),
LE or RE were ingested and PBS administered intraperi-
toneally.
Comet testing was according to Tice et al. (2000).
20Lofperipheralbloodwaswithdrawnfromeachanimal
by caudal vein puncturing, 24 h after treatment application.
Thismaterialwascarefullymixedwith120Loflowmelt-
ing-point agarose (LMP, 0.5%) at 37 °C and deposited on
pre-gelatinized slides. The slides were then placed in lysis
solution for at least 1 h. After denaturation (20 min) and al-
kaline electrophoresis (25V, 300mA, 20 min), the slides
wereneutralized,fixedandkeptrefrigerateduntilanalysis.,
when they were stained with ethidium bromide and exam-
ined visually using a fluorescence microscope (excitation
filterof420-490nmandemissionfilterof520nm),accord-
ingtoKobayashietal.(1995).Onehundredcellswereana-
lyzed per slide and per animal. The comets were classified
as:class0-nucleoidswithnotail;class1-nucleoidswitha
tail shorter than the diameter of the nucleoid itself; class 2 -
nucleoids with a tail 1 to 2 times the diameter of the
nucleoid;andclass3-nucleoidswithatailmorethantwice
the diameter.
In the micronucleus test, a few drops of blood drawn
from the caudal vein were placed on slides pre-stained with
acridine orange, and immediately cover-slipped (Hayashi
etal.,1990).Thisprocedurewasperformed48haftertreat-
mentadministration(inaccordancewiththeresultsofposi-
tive controls in our laboratory, and coinciding with the
highest peak in micronucleus induction). A total of 2000
reticulocytes were examined per slide per animal by fluo-
rescence-microscopy.
The data obtained in in vivo experiments were sub-
mitted to non-parametric analysis of variance (Kruskall-
Wallis), followed by Dunn’s test, with  = 0.05, using
GraphPad Instat
®, version 3.02 software.
Results
In the Ames test, the results indicated that only LE
had a mutagenic effect, albeit at very low potency (0.004
rev/g), whereas under other test conditions, mutagenicity
was not observed (Table 1). As to the root extract (RE),
mutagenic potency was not noted under any of the condi-
tions tested, although in the TA98 strain in the presence of
S9, this extract was highly toxic for Salmonella at all the
concentrations tested (p~1) (Table 2).
The results obtained in the comet and micronucleus
tests suggest that the treatment of animals with the leaf and
root extracts from Coccoloba mollis, and under the above
described experimental conditions, was not genotoxic.
The findings of the comet assay are presented in Fig-
ure 1. A statistically significant increase in DNA damage
only occurred in those animals treated with the DNA dam-
age-inducing agent cyclophosphamide. The same occurred
in the determination of micronuclei in reticulocytes. A sta-
tistically significant increase in the frequency of micro-
nuclei was seen only in animals treated with cyclophos-
phamide (Table 3).
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Table 1 - Data obtained in the evaluation of the mutagenicity of leaf extract (LE) from C. mollis with TA98 and TA100 Salmonella typhimurium strains
concurrent with or without metabolic activation (S9).
Dose (g/plate) TA98 - S9 TA 98+ S9 Dose (g/plate) TA100 - S9 TA 100 + S9
0 18  3.00 33.33  6.11 0 139  3.00 102.33  2.89
4NQO (TA98 - S9) or
2AA (TA 98+ S9)
520  105.83* 700  100.00* 4NQO (TA98 - S9) or
2AA (TA 98+ S9)
1030  62.44* 890  85.44
0.3 16.67  1.53 32  2.65 3 140.33  5.03 101.67  6.66
3 17.67  1.53 34  3.61 30 142  9.54 107.33  4.51
30 19  2.00 33.67  4.16 300 138.33  5.86 104.67  8.02
300 23.67  1.15 35.67  2.08 1000 140  11.36 116.33  15.37
3000 31.33  4.16* 41  5.57 2000 148.67  16.26 114.33  9.71
*Significant at 5%.
4NQO (0.5 g/plate) = positive control in tests without S9.
2AA (2.5 g/plate) = positive control in tests with S9.A dose-response relationship could be established for
the induction of DNA damage in comet assay by LE
(r = 0.939), but this was not evident in groups treated with
REwithregardtothedataongenotoxictyinbothassays.In
micronucleus test, the animals treated with LE2 and RE2
(6.6 x 10
-2 mg/kg b.w) showed a higher micronucleus fre-
quency than with LE3 and RE3 (6.6 x 10
-1 mg/kg b.w),
which could be indicative of extract cytotoxicity at this
dose.
Discussion
Interest in phytotherapy is generally motivated by its
traditional use and natural origin. Although many benefi-
cial biological activities have been scientifically corrobo-
rated, caution is called for in the public use of medicinal
plants. Although most phytotherapeutic products are con-
sidered safe if used at the recommended doses, untoward
effects can occur (Phillipson, 2007). Therefore,
genotoxicity/mutagenicity tests, such as those employed in
thepresentstudy,areimportantonevaluatingsafetyandef-
ficacy in natural products (Bast et al., 2002). In vivo tests
and the Salmonella/microsome assay are the most fre-
quently used and recommended by regulatory agencies for
determining genetic risk (FDA, 1997; OECD, 2001), since
theytakeintoaccountfactorsregardinginvivometabolism,
pharmacokinetics and DNA repair processes (Krishna and
Hayashi, 2000) and since the Salmonella/microsome assay
has a high predictive value for carcinogenicity in rodents
when a mutagenic response is obtained (Mortelmans and
Zeiger, 2000).
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Figure 1 - Mean score of comets observed in peripheral blood erythro-
cytesofmaleSwissmice24haftertreatmentwithextractsfromC.mollis.
Control: PBS; Cyclop.: cyclophosphamide - 50 mg/kg; RE1: 6.6 x
10
-3 mg/kg; RE2: 6.6 x 10
-2 mg/kg; RE3: 6.6 x 10
-1 mg/kg; LE1: 6.6 x
10
-3 mg/kg; LE2: 6.6 x 10
-2 mg/kg; LE3: 6.6 x 10
-1 mg/kg. RE = root
ethanolic extract from C. mollis; LE = leaf ethanolic extract from C.
mollis. **p < 0.01.
Table 2 - Data obtained in the evaluation of the mutagenicity of root extract (RE) from C. mollis with TA98 and TA100 Salmonella typhimurium strains
concurrent with or without metabolic activation (S9).
Dose (g/plate) TA98- S9 Dose (g/plate) TA 98+ S9 Dose (g/plate) TA100 - S9 TA 100 + S9
0 24.33  4.51 0 33.33  6.11 0 139  3.00 102.33  2.89
4NQO 520  105.83* 2AA 700  100.00* 4NQO (TA100 - S9) or
2AA (TA100+ S9)
1030  62.44* 890  85.44
5 19  2.65 0.005 T 5 139.33  4.51 108  5.57
50 17.67  2.08 0.05 T 50 142  4.36 116.67  7.09
500 21.67  2.52 0.1 T 100 144  6.0 117  7.0
3000 19.67  2.08 0.25 T 200 140.33  4.51 116  9.85
4000 21.33  1.53 0.5 T 300 151  9.54 114  8.89
T = toxic.
*Significant at 5%.
4NQO (0.5 g/plate) = positive control in tests without S9.
2AA (2.5 g/plate) = positive control in tests with S9.
Table 3 - Evaluation of genotoxicity of extracts from C. mollis, 48 h after
treatment of the animals. Number of experimental animals, total amount
of cells analyzed, total number of MNRETs and frequency of micronuclei
observed.
Treatment n Total of ana-
lyzed cells*
Total of cells
with MN
(MNRETs)
fi MN mean
 SD
control 7 10.000 37 7.4  2.88
cyclophosphamide 7 8.000 132 33.0  5.29**
RE1 7 14.000 66 9.42  3.73
RE2 7 10.000 67 13.4  7.23
RE3 7 14.000 82 11.71  6.1
LE1 7 14.000 82 11.71  3.49
LE2 7 14.000 126 18.0  7.07
LE3 7 14.000 88 12.57  5.85
Cyclophosphamide 50 mg/kg.
[LE1]/[RE1] (6.6 x 10
-3 mg/kg b.w. of LE or RE); [LE 2]/[RE 2] (6.6 x
10
-2 mg/kg b.w. of LE or RE); [LE 3]/[RE 3] (6.6 x 10
-1 mg/kg b.w. of LE
or RE).
* Variable number through the loss of material and not the death of ani-
mals during the experiment.
**p < 0.01.A preliminary analysis of the extracts of C. mollis by
the Salmonella/microsome system shows that they are not
mutagenic, except at the highest concentration of the leaf
extract (LE) tested in strain TA98, and in the absence of
metabolism. Thus, under these conditions this extract pos-
sibly induces a frameshift mutation, albeit at a very low
level, as this is the type of mutation detected by the TA98
strain. Furthermore, and under the same assaying condi-
tions, it was concluded that toxicity in the root extract (RE)
is greater than in the leaf (LE), due the high toxicity dis-
played in the TA98 strain, in the presence of metabolism.
These findings are in accordance with additional data on
cytotoxicity from our laboratory, where RE was shown to
bemoretoxicthanLEagainstHTCcells(proficientindrug
metabolism) (data not shown). Thus, the biotransformation
of compounds present in RE appears to be important in
their in vitro toxicity. Although comet formation (DNA
damage)andthefrequencyofmicronucleatedreticulocytes
(MNRETs) were increased in animals treated with LE and
RE, these were not statistically significant.
The use of C. mollis as both a memory modulator and
tranquilizer appears to have a certain scientific base. There
are reports on the tranquilizing efficacy of plant extracts
from the family Polygonaceae (Gosh et al., 2002), besides
the protective action of emodin (one of the anthraquinones
foundinRE)againstcerebraldisturbances(Guetal.,2000)
and in recuperating memory (Lu et al., 2007), although lit-
tle is still known about the genotoxic/mutagenic activities
of the anthraquinones, especially in vivo. Mueller and col-
leagues have attributed genotoxicity to emodin (Mueller et
al. 1998,1999; Mueller and Stopper 1999), whereas others
suggest that it is antimutagenic (Sun et al. 2000; Lee et al.
2005).BasedonstudiesbyMueller,emodin-inducedmuta-
genicity can be explained by either the formation of 2-hy-
droxyemodine via CYP1A2 and CYP2B or the inhibition
of topoisomerase II, due to the capacity of emodin, with its
planar structure, to intercalate DNA. Mutagenicity in the
TA1537 strain was shown when investigating the possible
mutagenic effects of anthraquinones and their metabolites
on different strains of Salmonella typhimurium (Tikkanen
et al., 1983; Masuda and Ueno 1984; Masuda et al., 1985;
Murakami et al., 1987; Westendorf et al., 1990; Krivobok
et al., 1992). Although emodin and physcion showed
mutagenicityinstrainTA1537ofSalmonellaaftermetabo-
lism, these anthraquinones were not mutagenic in strains
TA100, TA98 and TA2638 either in the absence or pres-
ence of metabolism (Krivobok et al., 1992; Mueller et al.,
1999; Lee et al., 2005).
Although many mutagenicity studies in vitro showed
apositiveresponse,alongtermstudycarriedoutbytheNa-
tional Toxicological Program (NTP) of the National Can-
cer Institute in the U.S. concluded that there was no evi-
dence of emodin possessing carcinogenic activity in male
F344/N rats and female B6C3F mice (NTP, 2001). Mengs
etal.(1997)alsodidnotobserveanygenotoxicorcytotoxic
effects following a single administration of a limited dose
of emodin (2 mg/kg b.wt.) in bone-marrow cells of NMRI
mice, thus reinforcing the importance of studies in diverse
test systems to obtain more reliable conclusions. In vivo,
the biotransformation of 1,8 dihydroxyanthraquinones (as
emodin and physcion) appears to occur in intestinal epithe-
lial and hepatic cells (Mueller et al., 1998), where the
biotransformation of emodin is mediated by P450
cytochrome enzymes (Tanaka et al., 1987; Go et al., 2007).
Longo et al. (2000), on studying the effects of various
anthraquinones on metabolic enzymes in the liver and in-
testine of rats, noted that the 1,8 dihydroxyanthraquinones
show the weakest induction of CYP1A2, this induction be-
ing significant only in the liver. This observation, together
withthepossibilitythattheconstituentsoftheextractsorof
their metabolites are free of mutagenic effect or are ex-
creted before causing damage, can explain in part the ab-
sence of genotoxicity/mutagenicity effects in vivo.O nt h e
otherhand,itisdifficulttostateorevensuggestareasonfor
this, mainly as regards LE, since little is still known about
the exact composition of this extract. Phytochemical
screening using pharmacognostic methodology has re-
vealed the presence of flavonoids and tannins in leaves and
roots, whereas results were negative for alkaloids, cou-
marins, saponins and simple phenolics (Barros et al., 2007,
2008).
Leaf extract from Coccoloba mollis analyzed by Oli-
veira et al. (2008), although extracted with different meth-
ods, also presented terpenes in its composition (simiarenol
and trans-phytol), besides two phytosteroids (sitostenone
and sitosterol). Sitosterol, in its beta form, is the most stud-
ied of these phytochemicals, and could be involved in the
possible cytotoxic effect found in micronucleus test, be-
cause it is known to induce apoptosis in many murine and
human cancerous cell lines in vitro, even at concentrations
considered to be very low (Janezic and Rao, 1992; Awad et
al.,2000;Moonetal,2007;Zhaoetal.,2009).Studieswith
oxidised products of -sitosterol in vitro (Maguire et al.,
2003; Lea et al., 2004) and in vivo (Abramsson-Zetterberg
et al., 2007) revealed neither genotoxic nor mutagenic ef-
fects.
In conclusion, through the use of Salmonella/micro-
some system and of the in vivo assays employed in our
work, we can conclude that the leaf and root extracts from
C. mollis posses low mutagenic response. Further studies
are still required for a better understanding of the biologi-
calactivitiesoftheextractsofC.mollis,astheyareimpor-
tant for scientifically confirming of the popularly
proposedeffectsandforprovidinggreatersafetytopeople
using this medicinal plant. However, the preliminary re-
sults, as presented for the first time, can be of aid in guid-
ing such investigations, and contribute to the future
registration and validation of this phytotherapeutic medi-
cine.
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